EUDA Health Holdings Ltd

EUDA Health Holdings Ltd (EUDA) Stock Analysis

$14.615

-0.403 (-2.76%)At close

Loading chart…
High
15.500
Open
15.460
VWAP
14.87
Vol
7.69K
Mkt Cap
146.48M
Low
14.500
Amount
114.42K
EV/EBITDA, TTM
0.00

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required.

AI analysis of EUDA Health Holdings Ltd (EUDA)

hold

EUDA Health Holdings is currently not a strong buy due to its significant year-to-date decline of 70.29% and a negative EPS forecast of -9.46 for Q4 2024. Although the stock has seen a recent 5-day increase of 10.64%, it remains under pressure from compliance challenges and a low current ratio of 0.18, indicating liquidity issues. The main risk is the Nasdaq compliance deadline, as the company must achieve a market value of at least $35 million by October 20, 2026, to avoid delisting.

Valuation Metrics

The current forward P/E ratio for EUDA Health Holdings Ltd (EUDA) is 7.81, compared to its 5-year average forward P/E of -7.41.

Forward P/E

Fair
5Y Average P/E
-7.41
Current P/E
7.81
Overvalued
21.06
Undervalued
-35.88

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-4.08
Current EV/EBITDA
0.00
Overvalued
1.31
Undervalued
-9.47

Forward P/S

Undervalued
5Y Average P/S
6.69
Current P/S
0.00
Overvalued
12.36
Undervalued
1.03

Events Timeline

2026-07-30 (ET)

08:00:00

EUDA Health Signs MOU with GO POSB to Advance Cell Therapy

2026-07-28 (ET)

06:30:00

EUDA Health Signs Tripartite MOU with GO POSB for Next-Gen Therapies

2026-07-14 (ET)

10:30:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility

2026-05-06 (ET)

09:40:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility Trading Pause

2026-04-29 (ET)

10:00:00

EUDA Health Holdings Ltd Trading Halted Due to Volatility

News

EUDA FAQ — answered by Alphio AI

EUDA Health Holdings Limited is a health technology company. The Company operates a southeast Asian digital healthcare ecosystem. Its unified artificial intelligence platform assesses patients' medical history, triages conditions, digitally connects patients with clinicians, and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. Its medical urgent care services provide healthcare assistance and medical evacuation to individual and corporate clients. Its property management service covers the management of properties, such as condominiums and shopping malls. Its services include e-triage, GP consult, e-medical certificates, and medical prescriptions. Its EUDA platform provides medical services from primary to post-surgery care and ongoing preventive healthcare for clients, regardless of the level of healthcare required. It operates in the Industrials sector (SERVICES-HEALTH SERVICES industry).

EUDA Health Holdings is currently not a strong buy due to its significant year-to-date decline of 70.29% and a negative EPS forecast of -9.46 for Q4 2024. Although the stock has seen a recent 5-day increase of 10.64%, it remains under pressure from compliance challenges and a low current ratio of 0.18, indicating liquidity issues. The main risk is the Nasdaq compliance deadline, as the company must achieve a market value of at least $35 million by October 20, 2026, to avoid delisting.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started